Drug
Antidepressant Aripiprazole
Antidepressant Aripiprazole: highest development phase Phase 3, developed by Otsuka. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Otsuka
Trials
| Drug | Phase | Indication |
|---|---|---|
| Antidepressant + Aripiprazole NCT00095745 | Phase 3 | Major Depressive Disorder |
Latest
No recent events.
Follow Antidepressant Aripiprazole on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.